JPRN-UMIN000006341
Not yet recruiting
未知
A randomized, open-label trial of ramelteon to prevent postoperative delirium in patients undergoing coronary artery bypass grafting - Trial of ramelteon to prevent postoperative delirium in patients undergoing coronary artery bypass grafting
Shimane University faculty of medicine0 sites50 target enrollmentSeptember 13, 2011
Conditionscoronary artery bypass grafting
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- coronary artery bypass grafting
- Sponsor
- Shimane University faculty of medicine
- Enrollment
- 50
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •hepatic impairment taking fluvoxamine maleate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Randomized controlled trials of ramelteon treatment for nocturia with sleep disorders after treatment for prostate cancer brachytherapy.Prostate cancerJPRN-UMIN000006711Yokohama city university school of medicine department of urology100
Active, not recruiting
Not Applicable
A randomised, controlled, open-label trial to compare brachial artery reactivity and cardiovascular risk of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple combination therapy containing DRV/r in HIV-1 infected subjects with undetectable plasma HIV-1 RNA on their current treatments. - NDEUCTR2008-002383-34-ITJANSSEN-CILAG
Active, not recruiting
Not Applicable
A randomised, controlled, open-label trial to compare the efficacy, safety and tolerability of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple combination therapy containing DRV/r in HIV-1 infected subjects with undetectable plasma HIV-1 RNA on their current treatments.HIV-1MedDRA version: 9.1Level: LLTClassification code 10020161Term: HIV infectionEUCTR2006-006437-40-ATJanssen-Cilag International NV250
Not yet recruiting
Not Applicable
Analyzing the requirements of platelets transfusion in stem cell transplant and high dose chemotherapy patients by giving with or without romiplostim.Health Condition 1: D708- Other neutropeniaCTRI/2021/12/038468Dr Sachin Suresh Jadhav
Active, not recruiting
Phase 1
A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/ritonavir versus lopinavir/ritonavir in treatment-naïve HIV-1 infected subjects. - This trial will be referred to as ARTEMIS.EUCTR2005-002486-36-GBTibotec Pharmaceuticals Limited